Works matching IS 03331024 AND DT 2023 AND VI 43 AND IP 9

Results: 4

Epidemiology, burden and clinical spectrum of cluster headache: a global update.
Published in:
Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231201577
By:
- Kim, Seung Ae;
- Choi, So Youn;
- Youn, Michelle Sojung;
- Pozo-Rosich, Patricia;
- Lee, Mi Ji
Publication type:
Article
Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up.
Published in:
Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231201576
By:
- García-Iglesias, Cristina;
- González-Celestino, Ana;
- Sierra Mencía, Álvaro;
- González Osorio, Yésica;
- Recio García, Andrea;
- Martínez-Badillo, Cristina;
- Echavarría Íñiguez, Ana;
- Varona-Galán, Berta;
- García-Azorín, David;
- Guerrero-Peral, Ángel Luis
Publication type:
Article
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study.
Published in:
Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231198792
By:
- van der Arend, Britt W. H.;
- Bloemhof, Mirthe M.;
- van der Schoor, Alle G.;
- van Zwet, Erik W.;
- Terwindt, Gisela M.
Publication type:
Article
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Published in:
Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231190296
By:
- Lipton, Richard B.;
- Halker Singh, Rashmi B.;
- Mechtler, Laszlo;
- McVige, Jennifer;
- Ma, Julia;
- Yu, Sung Yun;
- Stokes, Jonathan;
- Dabruzzo, Brett;
- Gandhi, Pranav;
- Ashina, Messoud
Publication type:
Article

Works matching IS 03331024 AND DT 2023 AND VI 43 AND IP 9

Epidemiology, burden and clinical spectrum of cluster headache: a global update.

Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up.

Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study.

Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.